Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Foundation Venture Capital Group Invests in Company Developing Plaque-Reducing Dental Hygiene Products

June 17, 2011 By Bio-Medicine.Org

NEW BRUNSWICK, N.J., June 17, 2011 /PRNewswire-USNewswire/ —
Affineti Biologics has received a commitment of up to $500,000 from
Foundation Venture Capital Group (FVCG) to advance its research in
the development of therapeutic and diagnostic products based on new
discoveries in oral biology and dental medicine.

According to James M. Golubieski, president of FVCG, the company
invested in Affineti because positive results from studies for
anti-caries and periodontal therapy look promising in their ability
to affect plaque reduction, influencing dental hygiene and systemic
medicine.

Affineti founder Dr. Daniel Fine, also a professor and chair,
Department of Oral Biology at UMDNJ-New Jersey Dental School,
believes the development of products based on his research will
prove more effective than others currently available.

His group uses biological principals to create hybrid or fusion
proteins that adhere to tissues with potent but non-toxic
antimicrobial effects.  He hopes to use these proteins to
deliver effective substances locally, avoiding systemic
complications. In the short term, Dr. Fine plans to use these
proteins in conditions related to the oral cavity and then expand
to include mucosal infections in other sites throughout the
body.

“We are focused on anti-caries, periodontal disease therapy and
dry mouth treatment,” Dr. Fine explained. “Additional testing for
yeast and bacterial overgrowth will allow us to bring our product
for an effective mouthwash for anti-caries, periodontitis and dry
mouth to clinical trials shortly.”

In addition to the adverse effect of plaque on dental health,
current research supports the idea that dental plaque buildup also
increases the risk of cardiovascular disease and stroke.

“The link between gum disease and cardiovascular disease is
strong enough for us to consider that Dr. Fine’s research will
impact health on many levels,” said Dr. George F. Heinrich, vice
chair and CEO of Fo

‘/>”/>

SOURCE

Related Articles Read More >

CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’
Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I

DeviceTalks Weekly.

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech